Concepedia

Kazuno Omori

KO

Statistics

Publications

14

Citations

286

H-Index

11

Active since

1984

Affiliations

Hokkaido University(Current)

Hokkaido University Hospital

Yokohama City University

Akebono Clinic

Sapporo Medical University Hospital

Kazuno Omori is an author at Hokkaido University specializing in metabolic syndrome, diabetes, and metabolism.

ORCID

Top concepts

Publications per year

1984–2022

14

Publications

14

Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone

Kyu Yong Cho, Akinobu Nakamura, Kazuno Omori et al. · Journal of Diabetes Investigation · 2020 · 53 citations · Full text

Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages

Kiyohiko Takahashi, Akinobu Nakamura, Hideaki Miyoshi et al. · Scientific Reports · 2018 · 35 citations · Full text

Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice

Kazuno Omori, Akinobu Nakamura, Hideaki Miyoshi et al. · Metabolism · 2019 · 34 citations

, , +14

Glucokinase Inactivation Paradoxically Ameliorates Glucose Intolerance by Increasing β-Cell Mass in <i>db/db</i> Mice

Kazuno Omori, Akinobu Nakamura, Hideaki Miyoshi et al. · Diabetes · 2021 · 22 citations · Full text

Simultaneous production of96Tc and111In by α-particle irradiation of stacked Nb and Ag foils, and their carrier-free separations

Takashi Omori, Kazuno Omori, C. Ochi et al. · Journal of Radioanalytical and Nuclear Chemistry · 1984 · 20 citations

, , +5

1–5 of 14